Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,008 | 272 | 76.2% |
| Travel and Lodging | $1,010 | 4 | 15.4% |
| Education | $494.99 | 19 | 7.5% |
| Gift | $62.68 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,613 | 84 | $0 (2024) |
| BLUEWIND MEDICAL | $1,154 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $386.85 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $336.43 | 17 | $0 (2024) |
| Axonics, Inc. | $273.26 | 6 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $244.32 | 13 | $0 (2024) |
| Allergan, Inc. | $207.16 | 16 | $0 (2022) |
| PFIZER INC. | $187.81 | 11 | $0 (2024) |
| Coloplast Corp | $183.06 | 11 | $0 (2022) |
| UROVANT SCIENCES INC | $157.51 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,836 | 38 | BLUEWIND MEDICAL ($1,154) |
| 2023 | $414.90 | 18 | Bayer Healthcare Pharmaceuticals Inc. ($84.85) |
| 2022 | $819.58 | 35 | Astellas Pharma US Inc ($262.60) |
| 2021 | $659.26 | 36 | Astellas Pharma US Inc ($257.52) |
| 2020 | $369.49 | 29 | Astellas Pharma US Inc ($92.98) |
| 2019 | $784.80 | 34 | Astellas Pharma US Inc ($343.78) |
| 2018 | $750.52 | 43 | Astellas Pharma US Inc ($189.53) |
| 2017 | $941.63 | 63 | Astellas Pharma US Inc ($380.87) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: HORMONE THERAPY | ||||||
| 11/13/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: BLADDER | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $42.22 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Oncology | ||||||
| 10/16/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: BLADDER | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $102.44 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $42.63 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: UROLOGY | ||||||
| 06/24/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: BLADDER | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Oncology | ||||||
| 06/04/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: UROLOGY | ||||||
| 05/01/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $60.41 | General |
| Category: Urology | ||||||
| 04/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: UROLOGY | ||||||
| 04/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA, AKEEGA | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 04/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Oncology | ||||||
| 04/04/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: ONCOLOGY | ||||||
| 04/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: UROLOGY | ||||||
| 04/01/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: BLADDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 4,879 | 149,423 | $436,083 | $172,739 |
| 2022 | 36 | 3,802 | 159,909 | $526,507 | $231,912 |
| 2021 | 27 | 3,265 | 187,731 | $665,511 | $335,628 |
| 2020 | 28 | 2,958 | 213,344 | $552,041 | $213,280 |
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 473 | 804 | $108,585 | $65,565 | 60.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 176 | $115,280 | $22,933 | 19.9% |
| 81007 | Urinalysis for bacteria | Office | 2023 | 303 | 470 | $14,100 | $13,651 | 96.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 51 | 834 | $20,850 | $7,831 | 37.6% |
| 84311 | Chemical analysis using spectrophotometry (light) | Office | 2023 | 304 | 844 | $7,258 | $6,637 | 91.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 261 | 372 | $13,020 | $6,574 | 50.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 27 | 35 | $9,870 | $5,951 | 60.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $7,380 | $4,793 | 64.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 430 | 670 | $67,000 | $4,514 | 6.7% |
| 84580 | Urobilinogen (metabolism substance) level, urine | Office | 2023 | 304 | 468 | $4,469 | $4,348 | 97.3% |
| 82010 | Ketone bodies analysis, quantitative | Office | 2023 | 303 | 470 | $4,230 | $3,722 | 88.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 264 | 394 | $3,152 | $3,089 | 98.0% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 51 | 140,722 | $19,701 | $2,918 | 14.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 71 | 102 | $6,732 | $2,473 | 36.7% |
| 82247 | Bilirubin level, total | Office | 2023 | 296 | 449 | $2,761 | $2,185 | 79.1% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 71 | 113 | $8,475 | $2,181 | 25.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $3,300 | $1,990 | 60.3% |
| 83069 | Urine hemoglobin level | Office | 2023 | 302 | 469 | $2,251 | $1,796 | 79.8% |
| 82945 | Glucose (sugar) level on body fluid | Office | 2023 | 303 | 470 | $2,256 | $1,792 | 79.4% |
| 84156 | Total protein level, urine | Office | 2023 | 295 | 447 | $2,012 | $1,595 | 79.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 210 | 243 | $1,458 | $1,364 | 93.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 28 | 76 | $2,432 | $1,155 | 47.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 272 | 465 | $3,720 | $1,000 | 26.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 20 | 44 | $2,640 | $910.57 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $1,500 | $874.83 | 58.3% |
About Dr. John Pirani, MD
Dr. John Pirani, MD is a Urology healthcare provider based in Gadsden, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942267026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Pirani, MD has received a total of $6,576 in payments from pharmaceutical and medical device companies, with $1,836 received in 2024. These payments were reported across 296 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,008).
As a Medicare-enrolled provider, Pirani has provided services to 14,904 Medicare beneficiaries, totaling 710,407 services with total Medicare billing of $953,558. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Gadsden, AL
- Active Since 05/01/2006
- Last Updated 01/06/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1942267026
Products in Payments
- REVI (Device) $1,154
- XTANDI (Drug) $734.62
- GEMTESA (Drug) $384.29
- Myrbetriq (Drug) $373.89
- Nubeqa (Drug) $282.26
- Axonics (Device) $259.25
- Xtandi (Drug) $229.80
- BOTOX (Biological) $181.05
- ELIGARD (Drug) $147.53
- XIAFLEX (Biological) $145.07
- Surgical wound closure product (Medical Supply) $135.63
- ERLEADA (Drug) $132.93
- MYRBETRIQ (Drug) $130.89
- PROVENGE (Drug) $125.29
- PERI-STRIPS DRY (Biological) $119.22
- INTERSTIM (Device) $117.24
- Noctiva (Drug) $116.89
- Erleada (Drug) $105.88
- Xofigo (Drug) $104.59
- ZYTIGA (Drug) $97.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Gadsden
Dr. Merle Wade, Md, MD
Urology — Payments: $8,570
Michael Jennings, Md, MD
Urology — Payments: $8,457
Dr. Manish Shah, Md, MD
Urology — Payments: $5,545
Dr. Marilyn Kelleher, M.d, M.D
Urology — Payments: $3,243
Dylan Dangerfield, M.d, M.D
Urology — Payments: $488.44
George Walker, Md, MD
Urology — Payments: $12.17